AV
AVG.LSE Avingtrans Plc
- Market cap
- GBX 281M
- P/E
- 40.0x
- P/B
- 2.25x
- ROE
- 5.4%
- Dividend yield
- 0.66%
- Fundamental score
- -
Ratios use the latest price and the fiscal year ending May 2026.
Is AVG.LSE undervalued?
Graham numberAVG.LSE trades 99.8% above its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Avingtrans Plc fundamental analysis
No fundamental analysis for Avingtrans Plc yet.
Avingtrans Plc stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Avingtrans Plc
Avingtrans plc, together with its subsidiaries, provides engineered components, systems, and services to the energy, medical, and infrastructure industries worldwide. It operates in two segments, Energy-AES and Medical-MII. The Energy-AES segment designs, manufactures, and services electric motor and pumps, gas compressors, pressure vessels, blast doors, and containers. Its Medical-MIII segment designs and manufactures medical diagnostic equipment; pressure, vacuum vessels, …
Full company profileAvingtrans Plc financial statements
Avingtrans Plc annual financial statements (GBP; K = thousand, M = million, B = billion, T = trillion)
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||||
| Revenue | 22.7M | 78.9M | 104M | 92.0M | 98.5M | 99.1M | 116M | 137M | 156M | 163M |
| Gross Profit | 4.06M | 20.1M | 27.7M | 22.2M | 28.4M | 32.6M | 36.9M | 44.0M | 47.4M | 51.4M |
| Operating Income | 43.0K | -3.82M | 3.66M | 1.19M | 6.09M | 7.19M | 8.24M | 5.64M | 8.55M | 10.5M |
| EBITDA | 398K | 2.21M | 8.89M | 6.95M | 11.0M | 12.0M | 13.2M | 12.5M | 15.8M | 18.5M |
| Net Income | -296K | -4.49M | 2.51M | 1.39M | 3.99M | 6.48M | 5.19M | 3.66M | 6.56M | 6.75M |
| EPS | -0.01 | -0.16 | 0.08 | 0.04 | 0.12 | 0.20 | 0.16 | 0.11 | 0.19 | 0.20 |
| Balance Sheet | ||||||||||
| Total Assets | 54.5M | 122M | 122M | 131M | 143M | 155M | 155M | 186M | 193M | 215M |
| Total Liabilities | 9.58M | 52.7M | 53.0M | 61.3M | 43.7M | 48.9M | 47.0M | 73.3M | 77.5M | 87.8M |
| Shareholders' Equity | 44.9M | 69.1M | 69.3M | 69.9M | 97.3M | 104M | 106M | 110M | 113M | 125M |
| Cash & Short-term Investments | 27.7M | 6.57M | 8.91M | 5.09M | 30.1M | 24.3M | 17.7M | 12.1M | 8.56M | 7.98M |
| Total Debt | 1.25M | 13.7M | 10.9M | 21.4M | 9.80M | 11.0M | 8.58M | 24.0M | 25.5M | 23.5M |
| Cash Flow | ||||||||||
| Operating Cash Flow | -3.26M | -6.89M | 9.03M | -51.0K | 6.37M | 3.71M | 9.57M | 1.33M | 11.6M | 14.6M |
| Capital Expenditure | 484K | 2.65M | 2.34M | 4.74M | 2.42M | 4.99M | 8.69M | 12.4M | 2.81M | 4.10M |
| Free Cash Flow | -3.74M | -9.55M | 6.68M | -4.80M | 3.96M | -1.28M | 875K | -11.1M | 8.80M | 10.5M |
| Ratios | ||||||||||
| ROE | -0.7% | -6.5% | 3.6% | 2.0% | 4.1% | 6.2% | 4.9% | 3.3% | 5.8% | 5.4% |
| ROA | -0.5% | -3.7% | 2.1% | 1.1% | 2.8% | 4.2% | 3.3% | 2.0% | 3.4% | 3.1% |
| Net Profit Margin | -1.3% | -5.7% | 2.4% | 1.5% | 4.0% | 6.5% | 4.5% | 2.7% | 4.2% | 4.1% |
| Debt to Equity | 0.03x | 0.20x | 0.16x | 0.31x | 0.10x | 0.11x | 0.08x | 0.22x | 0.23x | 0.19x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Avingtrans Plc dividends
- Dividend yield
- 0.66%
- Forward dividend
- 0.05 GBX
- Payout ratio
- 23.6%
- Ex-dividend date
- Nov 5, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2026 | GBP 1.59M | 0.05 | 23.6% |
| 2025 | 1.53M | 0.05 | 23.3% |
| 2024 | GBP 1.44M | 0.04 | 39.4% |
| 2023 | GBP 1.33M | 0.04 | 25.6% |
| 2022 | GBP 1.27M | 0.04 | 19.5% |
| 2021 | GBP 1.19M | 0.04 | 29.9% |
| 2020 | GBP 1.19M | 0.04 | 86.0% |
| 2019 | GBP 1.12M | 0.04 | 44.5% |
| 2018 | GBP 906K | 0.03 | - |
| 2017 | GBP 886K | 0.04 | - |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 473:470 on Sep 15, 2004.
Who owns Avingtrans Plc
- Insiders 16.62%
- Institutions 44.62%
- Public & others 38.76%
- Shares outstanding 36.9M
- Free float 27.9M
Avingtrans Plc company profile
- Company name
- Avingtrans Plc
- Ticker
- AVG.LSE
- ISIN
- GB0009188797
- Exchange
- London Exchange
- Sector
- Industrials
- Industry
- Machinery
- Employees
- 1,029
- Fiscal year end
- May
- Address
- Chatteris Business Park, Chatteris, United Kingdom, PE16 6SA
- Phone
- 44 1354 692 391
- Website
- avingtrans.plc.uk
About Avingtrans Plc
Avingtrans plc, together with its subsidiaries, provides engineered components, systems, and services to the energy, medical, and infrastructure industries worldwide. It operates in two segments, Energy-AES and Medical-MII. The Energy-AES segment designs, manufactures, and services electric motor and pumps, gas compressors, pressure vessels, blast doors, and containers. Its Medical-MIII segment designs and manufactures medical diagnostic equipment; pressure, vacuum vessels, and composite materials for research organisations; and superconducting magnets and helium-free cryogenic systems in magnetic resonance imaging and nuclear magnetic resonance. The company sells its products under the Hayward Tyler, Energy Steel, Slack & Parr, Stainless Metalcraft, Booth Industries, Ormandy Rycroft Engineering, Composite Products, Adaptix, Magnetica, Tecmag, and Scientific Magnetics brands. The company was formerly known as Frank Usher Holding plc and changed its name to Avingtrans plc in November 2000. Avingtrans plc was incorporated in 1985 and is based in Chatteris, the United Kingdom.
Avingtrans Plc management
5- Mr. Stephen McQuillanCEO, MD & Executive Director · born 1961
- Mr. Stephen Michael King ACA, BEng.CFO, Company Secretary & Executive Director · born 1966
- Mr. Austen M. AdamsCOO & Director · born 1965
- Mr. Willem BaraltChairman of Medical & Industrial Imaging
- Mr. Stuart Arthur GallChief Executive Officer of Medical & Industrial Imaging · born 1962